Close Menu

NEW YORK – German firms Gilupi and Cellink subsidiary Scienion said on Thursday that they plan to extend an collaboration that started in 2018 on single circulating tumor cell (CTC) analysis.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.